Beroni Group Ltd

Chart & performance

D1W1MN

P/E

—

P/S

205.49

EPS

—

Vol. 1Y

—

Shs. 5Y

-15.79%

Rev. 5Y

-18.67%

Div Yld LY

—

Div Yld TTM

—

Revenues

638k

+101.47%

Net income

-4m

L-60.18%

CFO

-2m

L-24.71%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of FDA/CE approved virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products, and a development pipeline targeting oncology and cell therapies. The company has operations in Australia, the United States, China, and Japan.

URL

https://www.beronigroup.com/

IPO date

May 12, 2017

Employees

Domiciled in

Incorporated in

Headquarters & legal address

L36, GATEWAY TOWER
1 MACQUARIE PLACE
SYDNEY, NSW 2000
AU

Valuation

Latest on right Latest on left

Title AUD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title AUD in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT